Half Year Results

About this update from Diploma Plc

[{"type":"text","content":"\n \n \n \n \n \n \n \n \n \n \n \n \n DIPLOMA PLC \n \n \n     10-11 CHARTERHOUSE SQUARE, LONDON EC1M 6EE \n     TELEPHONE: +44 (0)20 7549 5700 \n \n \n \n \n HALF YEAR RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2024 \n   \n Strong first half, full year upgrade \n   \n \n \n \n \n   \n \n \n H1 24 \n \n \n H1 23 \n \n \n Change \n \n \n \n \n Revenue \n \n \n £638.3m \n \n \n £582.8m \n \n \n +10% \n \n \n \n \n Organic revenue growth \n \n \n 5% \n \n \n 10% \n \n \n   \n \n \n \n \n Adjusted operating profit \n \n \n £125.4m \n \n \n £109.7m \n \n \n +14% \n \n \n \n \n Adjusted operating margin \n \n \n 19.6% \n \n \n 18.8% \n \n \n +80bps \n \n \n \n \n Statutory operating profit (1) \n \n \n £88.0m \n \n \n £92.5m \n \n \n (5%) \n \n \n \n \n Free cash flow \n \n \n £66.3m \n \n \n £51.8m \n \n \n +28% \n \n \n \n \n Free cash flow conversion \n \n \n 76% \n \n \n 70% \n \n \n +6ppts \n \n \n \n \n Adjusted earnings per share \n \n \n 65.1p \n \n \n 59.1p \n \n \n +10% \n \n \n \n \n Basic earnings per share (1) \n \n \n 43.1p \n \n \n 47.3p \n \n \n (9%) \n \n \n \n \n Leverage \n \n \n 0.9x \n \n \n 0.7x \n \n \n   \n \n \n \n \n Interim dividend per share \n \n \n 17.3p \n \n \n 16.5p \n \n \n +5% \n \n \n \n \n ROATCE \n \n \n 18.0% \n \n \n 17.8% \n \n \n +20bps \n \n \n \n \n All alternative performance measures are defined in note 13 to the Condensed Consolidated Financial Statements. \n 1 Statutory operating profit and basic earnings per share in the prior year include an exceptional gain on the disposal of Hawco of £12.2m. \n   \n \n \n \n \n • \n \n \n Organic revenue growth of 5%, volume-led with good momentum into the second half. \n \n \n \n \n • \n \n \n Double digit reported revenue growth includes 8% from acquisitions and an adverse 3% impact of foreign exchange translation.  \n \n \n \n \n • \n \n \n Adjusted operating margin up 80 bps to 19.6%, reflecting our value-add proposition; operational leverage; disciplined cost management; and accretive acquisitions. \n \n \n \n \n • \n \n \n Delivered with discipline: ROATCE up 20bps to 18.0%; free cash flow conversion up 6ppts to 76%, and leverage at 0.9x. \n \n \n \n \n • \n \n \n Ca. £284m invested in six quality acquisitions, including Peerless for ca. £236m and PAR Group for ca. £38m, which completed after the period end. \n \n \n \n \n • \n \n \n Upgrading guidance: we now expect FY24 constant currency revenue growth of ca. 16% (comprising 6% organic growth and 10% from acquisitions), and an operating margin of ca. 20.5%. Strong underlying performance and recent acquisitions contribute equally to the upgrade to operating margin. \n \n \n \n \n Commenting, Johnny Thomson, Diploma's Chief Executive said: \n \n \n \n \n \"Thank you to all my brilliant colleagues for their continued dedication and passion for serving our customers and driving our performance. We've delivered another strong first half with good volume-led organic growth in a more challenging market environment. Our momentum is encouraging going into the second half, underpinning our upgrade to full year guidance. \n   \n \"We have welcomed six new quality businesses into the Group since the start of the year. They include Peerless and PAR Group - two founder-owned businesses with great organic growth credentials and strong value-add business models.   \n   \n \"Diploma has a long track record of double-digit EPS growth at healthy returns. Our current performance and upgrade reaffirms our confidence in delivering sustainable quality compounding.\" \n   \n \n \n \n \n   \n Revenue diversification driving organic growth and increasing resilience \n \n \n \n \n • \n \n \n Controls +7% : Strong growth in International Controls with structural tailwinds and market share gains. Windy City Wire delivered sustained, volume-led growth in line with Group average. \n \n \n \n \n • \n \n \n Seals +1% : Resilient performance against a backdrop of customer destocking. Normal ordering patterns are starting to resume and we expect a stronger second half.   \n \n \n \n \n • \n \n \n Life Sciences +5% : End market dynamics are now largely normalised post-pandemic, underpinning strong performance in Canada and Australia. \n \n \n \n \n   \n Complementary acquisitions driving future organic growth \n \n \n \n \n • \n \n \n Acquisition of US-based Peerless Aerospace Fastener LLC (\"Peerless\") for ca. £236m, extending our established position in aerospace specialty fasteners and accelerating organic growth through product and geographic expansion. It is expected to deliver 15% ROATCE and 8% EPS accretion in year one. \n \n \n \n \n • \n \n \n Acquisition of UK-based Plastic and Rubber Group Holdings Limited (\"PAR Group\") for ca. £38m adds scale to R&G's Seals & Gaskets division. It is expected to deliver 14% ROATCE and 1% EPS accretion in year one. \n \n \n \n \n • \n \n \n Four small bolt-ons for £10m; average EBIT multiple around 4x; £10m of annual revenue; and year one ROATCE of over 20%. \n \n \n \n \n • \n \n \n Strong M&A pipeline diversified by Sector, size and geography. Strong cash flow and balance sheet provides capacity for disciplined acquisitive growth. \n \n \n \n \n   \n Scaling effectively for sustainable growth \n \n \n \n \n • \n \n \n Expansion of the 'Leadership at Scale' management development programme. \n \n \n \n \n • \n \n \n Three new state-of-the-art facilities opened to support future growth in the UK and Europe. \n \n \n \n \n • \n \n \n Delivered improvements against all our Delivering Value Responsibly targets. \n \n \n \n \n • \n \n \n Strengthened balance sheet through the refinancing of the Group's facilities with a structured Revolving Credit Facility (\"RCF\") and debut US Private Placement (\"USPP\") providing ca. £770m of committed facilities with a blend of maturities out to 2036. \n \n \n \n \n   \n Upgrading full year 2024 guidance \n \n \n \n \n • \n \n \n The momentum in our underlying business, combined with the contribution from recent acquisitions, drives an upgrade to previous guidance for FY24: \n \n \n \n \n \n \n \n ○ \n \n \n Constant currency revenue growth of ca. 16%, up 5ppts from previous guidance, comprising ca. 6% organic revenue growth and growth from acquisitions of ca. 10%. \n \n \n \n \n \n \n \n ○ \n \n \n Strong operating margin of ca. 20.5%, up 80bps from previous guidance. Strong underlying performance and recent acquisitions contribute equally to the upgrade. \n \n \n \n \n \n \n \n ○ \n \n \n EPS growth of ca. 15%, reflecting strong underlying performance and the contribution of acquisitions. \n \n \n \n \n \n \n \n ○ \n \n \n Free cash flow conversion of ca. 90% and leverage of 1.3x. \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Notes: \n   \n 1.        Diploma PLC uses alternative performance measures as key financial indicators to assess the underlying performance of the Group. These include revenue and organic growth, adjusted operating profit/adjusted operating margin, adjusted earnings per share, free cash flow/free cash flow conversion, leverage and ROATCE. The narrative in this Announcement is based on these alternative measures and an explanation is set out in note 13 to the Condensed Consolidated Financial Statements in this Announcement. \n   \n 2.        Certain statements contained in this Announcement constitute forward-looking statements. Such forward-looking statements involve risks, uncertainties and other factors which may cause the actual results, performance or achievements of Diploma PLC, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such statements. Such risks, uncertainties and other factors include, among others, exchange rates, general economic conditions and the business environment. \n   \n A presentation of the results to analysts and investors will be held at 09:00 GMT via audio conference call and webcast. Register your attendance for the webcast at: https://brrmedia.news/DPLM_HY24 \n   \n Conference call dial in details: \n \n \n \n \n • \n \n \n Dial in: UK-Wide: +44 (0) 33 0551 0200 / UK Toll Free: 0808 109 0700 \n \n \n \n \n • \n \n \n Password: Diploma Half Year \n \n \n \n \n   \n \n \nA recording of the presentation will be available after the event on our website: https://www.diplomaplc.com/investors/financial-presentations/ \n   \n \n   \n \n \n \n \n For further information please contact: \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Diploma PLC - \n \n \n +44 (0)20 7549 5700 \n \n \n \n \n Johnny Thomson, Chief Executive Officer \n \n \n   \n \n \n \n \n Chris Davies, Chief Financial Officer \n \n \n \n \n \n \n \n Holly Gillis, Head of Investor Relations \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Teneo - \n \n \n +44 (0)20 7353 4200 \n \n \n \n \n Martin Robinson \n \n \n \n \n \n \n \n Camilla Cunningham \n \n \n \n \n \n \n \n   \n   \n NOTE TO EDITORS: \n Diploma PLC is a decentralised, value-add distribution Group. Our businesses deliver practical and innovative solutions that keep key industries moving - from energy and infrastructure to healthcare. \n   \n We are a distribution group with a difference. Our businesses have the technical expertise, specialist knowledge, and long-term relationships required to deliver value-add products and services that make our customers' lives easier. These value-add solutions drive customer loyalty, market share growth and strong margins. \n   \n Our decentralised model means our specialist businesses are agile and empowered to deliver the right solutions for their customers, in their own way. As part of Diploma, our businesses can also leverage the additional resources, opportunities and expertise of a large, international and diversified Group to benefit their customers, colleagues, suppliers and communities. \n   \n We employ ca. 3,500 colleagues across our three Sectors of Controls, Seals and Life Sciences. Our principal operating businesses are located in the UK, Northern Europe, North America and Australia. \n   \n Over the last fifteen years, the Group has grown adjusted earnings per share (\"EPS\") at an average of ca. 15% p.a. through a combination of organic growth and acquisitions. \n \n Diploma is a member of the FTSE 100. \n   \n Further information on Diploma PLC can be found at www.diplomaplc.com \n   \n The person responsible for releasing this Announcement is John Morrison, Company Secretary. \n LEI: 2138008OGI7VYG8FGR19 \n   \n BUSINESS REVIEW \n \nStrong first half performance \n The Group has delivered a strong first half performance as we continue to execute our strategy of building high quality scalable businesses for sustainable organic growth. \n   \n Revenue diversification driving organic growth and increasing resilience Revenue in the year grew 10% to £638.3m (H1 23: £582.8m). Organic growth of 5% was volume-led, with growth across all three Sectors. Acquisitions added a further 8% to reported revenue, partially offset by the adverse 3% impact of foreign exchange translation. \n   \n \n \n \n \n   \n \n \n Revenue £m \n \n \n   \n \n \n Organic growth \n \n \n \n \n   \n \n \n H1 24 \n \n \n H1 23 \n \n \n Change \n \n \n H1 24 \n \n \n H1 23 \n \n \n \n \n   \n \n \n   \n \n \n   \n \n \n   \n \n \n   \n \n \n   \n \n \n \n \n Controls \n \n \n 288.1 \n \n \n 278.8 \n \n \n +3% \n \n \n +7% \n \n \n +13% \n \n \n \n \n Seals \n \n \n 241.2 \n \n \n 198.4 \n \n \n +22% \n \n \n +1% \n \n \n +8% \n \n \n \n \n Life Sciences \n \n \n 109.0 \n \n \n 105.6 \n \n \n +3% \n \n \n +5% \n \n \n +4% \n \n \n \n \n   \n \n \n   \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Group \n \n \n 638.3 \n \n \n 582.8 \n \n \n +10% \n \n \n +5% \n \n \n +10% \n \n \n \n \n   \n This strong revenue performance was replicated across all our key financial metrics: \n \n \n \n \n • \n \n \n Operating margins rose 80bps to 19.6% (H1 23: 18.8%), supported by operational leverage, disciplined cost control and accretive acquisitions. Adjusted operating profit was up 14% to £125.4m (H1 23: £109.7m). \n \n \n \n \n • \n \n \n Adjusted earnings per share (\"EPS\") grew 10% to 65.1p (H1 23: 59.1p), continuing our long-term compounding track record of double-digit growth (15% CAGR EPS growth over 15 years).  \n \n \n \n \n • \n \n \n Cash conversion improved year on year to 76% (H1 23: 70%) reflecting continued disciplined working capital management. \n \n \n \n \n • \n \n \n Return on capital is a key underpin of our compounding financial model. In the period, return on adjusted trading capital employed (\"ROATCE\") rose 20bps to 18.0% (H1 23: 17.8%). \n \n \n \n \n   \n In line with our policy, we have declared a 5% increase in the interim dividend to 17.3p per share (H1 23: 16.5p), payable on 7 June 2024 to shareholders on the register on 24 May 2024, with a corresponding ex-dividend date of 23 May 2024. \n   \n Positioning behind structurally growing end markets \n We continue to drive growth through expansion in structurally growing end markets. In Controls , we have increased our position in aerospace, organically and through the recent acquisition of Peerless Aerospace Fastener LLC (\"Peerless\") and have also seen strong growth in space, motorsport, defence, medical, energy and data centres. In Seals , we continue to see growth in markets benefiting from sustained infrastructure investment, as well as energy markets and the mining of minerals for batteries required for electrification. In Life Sciences , continued investment in In Vitro Diagnostics from health authorities has driven growth across a range of applications. \n   \n Penetration of core developed economies \n In Controls, the acquisition of Peerless extends our geographic reach in the US from the West Coast to national coverage, and also extends our capabilities in Europe. In Seals , we have begun to explore opportunities to leverage our sales platforms and distribution networks across our businesses. Our European and UK fluid power businesses, DICSA and R&G, are collaborating to expand their respective markets, and in the US, DICSA is working with Hercules Aftermarket to enhance its distribution capability out of the Louisville Autostore. We are in the early stages of these collaborations but believe they will yield exciting opportunities. In Life Sciences we have a scaling programme underway in Canada that will see the creation of eastern and western hubs, enabling better customer coverage across the country. \n   \n Product range extension \n In the first half, our product offering has grown organically, as we source and develop new products, and through acquisition. In Controls , Windy City Wire (\"WCW\") introduced Audio/Visual (\"AV\") cabling to its product range driving growth from existing and new customers. Interconnect expanded its offering of motorsport connectors which was a strong driver of growth in the period. In Seals , R&G has continued to extend its range into adjacent product lines, including DICSA stainless steel fittings, and VSP increased its position in industrial and transportation markets through product developments. In Life Sciences , the continued adoption of new technologies in areas including urology, gynaecology and endoscopy has created opportunities for product expansion and we are increasingly leveraging products between geographies. \n   \n Complementary acquisitions to accelerate growth \n Future organic growth is also supported by selective acquisitions. Since 30 September 2023, we have acquired six high-quality businesses for a total of £284m. \n   \n During the period, we completed four quality bolt-on acquisitions for £10m, with an EBIT multiple of around 4x and year one ROATCE exceeding 20%. These acquisitions include Controls and Seals businesses in the UK and Europe with more details included in the Sector reviews. \n   \n On 1 May, we completed the acquisition of US-based Peerless for ca. £236m. This former family-owned business extends our established position in the aerospace specialty fasteners market, in the Controls Sector, accelerating organic growth through product and g eographic expansion. This is highly complementary to our existing Specialty Fasteners business, extending our capabilities from the interior of the aircraft cabin, to the airframe. Acquired at a multiple of ca. 7x FY24 earnings before interest and tax (\" EBIT\"), Peerless is expected to deliver 15% ROATCE and 8% EPS accretion in year one. \n   \n On 30 April, we acquired UK-based PAR Group for ca. £38m. This founder-led business will join the R&G family of companies in our Seals Sector, adding scale to its Seals & Gaskets division. Acquired at ca. 7x FY24 EBIT, PAR Group is expected to deliver 14% ROATCE and 1% EPS accretion in year one. \n   \n Given the completion dates of both Peerless and PAR Group, there is no impact from either in the first half results. \n   \n Our acquisition pipeline remains strong with active opportunities across our core geographies and in all three Sectors. \n   \n The recent acquisitions demonstrate the compelling proposition Diploma offers to owners selling their businesses. Finding the right home is often an important part of their decision and we have a strong track record of preserving legacies; promoting autonomy and accountability; supporting growth through investment and expertise; and welcoming new colleagues into our network through which we all benefit from shared experience. \n   \n Scaling the Businesses and the Group \n Delivering our strategy of building high-quality businesses for sustainable organic growth requires that we scale the businesses, developing their operating models to continue to deliver great customer propositions at scale. At the same time, we are developing the Group, evolving our structures, capabilities and culture to support this growth and maintain discipline and appropriate controls. \n   \n Scaling takes many forms across the Group and is an ongoing journey. From the upgrade of systems and facilities, such as new state-of-the-art facilities in UK Wire and Cable ( Controls ), UK Aftermarket and European OEM ( Seals ), to enhancing sales capabilities, such as in Interconnect and Industrial Automation ( Controls ) we are continually investing in scaling our businesses. In Life Sciences , we are increasingly collaborating across geographies to leverage strong supplier and product relationships from one business to bring new and improved customer offers to other regions. Through our Leadership at Scale programme, we are developing internal senior talent and building succession, and are investing in growing talent through our apprenticeship programmes across the Group. \n   \n Delivering Value Responsibly \n We have made good progress in the period across all aspects of DVR: \n \n \n \n \n • \n \n \n In Q1 we launched a Groupwide Health & Safety framework, alongside the introduction of an external Health & Safety audit program to support our businesses in driving continuous improvement. \n \n \n \n \n • \n \n \n In December, our Net Zero targets were validated by SBTi. We are targeting a 50% reduction in Scope 1&2 emissions and 30% reduction in Scope 3 by 2030, leading to net zero by 2045. \n \n \n \n \n • \n \n \n We continue to focus on gender equality across all our businesses and in the first half of the year we had gender parity across all hires into our senior leadership teams. \n \n \n \n \n   \n Outlook and full year guidance \n We have delivered a strong first half with good momentum going forward. The positive momentum from our underlying business, combined with the contribution from new acquisitions drives an upgrade to previous guidance for FY24: \n   \n \n \n \n \n • \n \n \n Constant currency revenue growth of ca. 16%, up 5ppts from previous guidance, comprising ca. 6% organic revenue, and growth from acquisitions of ca. 10%. \n \n \n \n \n • \n \n \n Strong operating margin of ca. 20.5%, up 80bps from previous guidance. Strong underlying performance and recent acquisitions contribute equally to the upgrade. \n \n \n \n \n • \n \n \n EPS growth of ca. 15% reflecting strong underlying performance and the contribution of acquisitions. \n \n \n \n \n • \n \n \n Free cash flow conversion of ca. 90% and leverage of 1.3x. \n \n \n \n \n   \n SECTOR REVIEW: CONTROLS \n   \n The Controls Sector businesses supply specialised wiring, cable, connectors, fasteners, control devices, adhesives, and Computer Numerical Control (\"CNC\") and robotic components for a range of technically demanding applications. \n   \n \n \n \n \n \n \n \n H1 24 \n \n \n H1 23 \n \n \n Change \n \n \n \n \n Revenue \n \n \n £288.1m \n \n \n £278.8m \n \n \n +3% \n \n \n \n \n Organic revenue growth \n \n \n +7% \n \n \n +13% \n \n \n \n \n \n \n \n Statutory operating profit \n \n \n £53.7m \n \n \n £57.7m \n \n \n (7%) \n \n \n \n \n Adjusted operating profit \n \n \n £69.9m \n \n \n £64.3m \n \n \n +9% \n \n \n \n \n Adjusted operating margin \n \n \n 24.3% \n \n \n 23.1% \n \n \n +120bps \n \n \n \n \n                                     \n H1 24 highlights \n \n \n \n \n • \n \n \n Share gains in fast growing end markets in the US, UK and Europe drove strong 7% organic revenue growth. \n \n \n \n \n • \n \n \n Adjusted operating profit of £69.9m grew 9%, with a 120bps year-on-year increase in adjusted operating margin to 24.3%. Margin expansion was driven by product mix, operating leverage and margin accretive acquisitions in the prior year. \n \n \n \n \n • \n \n \n Strategic acquisition of Peerless builds scale and expands Specialty Fasteners' presence in key US and European civil aerospace and defence markets. \n \n \n \n \n   \n International Controls (61% of Controls Sector revenue 1 ) delivered 10% organic growth in the period, continuing to benefit from market share gains and strong commercial delivery in civil aerospace and space markets, and enduring tailwinds in UK and European defence and energy markets as investment in these areas remains a prime focus for governments. International Controls continues to diversify its end markets, gaining share in space and medical and benefiting from the wider move to electrification and green energy as it continues to deliver growth in the electric vehicle (\"EV\") and renewable energy end markets. Operating margin improved considerably, principally due to positive operating leverage on volume growth and mix benefits from the acquisition of Industrial Automation business, T.I.E., and the disposal of Hawco, in the prior year. Reported revenue in H1 23 included £15.1m contribution from Hawco, prior to its disposal in March 2023. \n   \n 1 Including proforma revenue for Peerless which completed after the period end \n   \n Windy City Wire (\"WCW\") (39% of Controls Sector revenue) continues to deliver growth in its core building automation end market, benefiting during the period from the expansion in datacentres behind AI growth, which we expect to provide longer term growth impetus. Organic growth of 4% was supported by the continued acceleration of growth in newer applications, including Distributed Antenna Systems (\"DAS\"), AV and the roll-out of chip-and-pin terminals to gas stations across the US. Operating margin improved further, driven by positive operating leverage and mix benefits of moving into higher margin end markets and products. \n   \n Revenue diversification driving organic growth \n We delivered high single-digit organic growth in our Interconnect businesses, driven by robust demand in the defence, motorsport and civil aerospace markets. Revenues in the German energy market also grew, driven by share gains and ongoing upgrades to the transmission and distribution network. Other key growth segments include medical and US industrial, where we are gaining market share as these end markets recover post-pandemic. \n   \n Our Specialty Fasteners businesses continued to deliver strong double-digit growth during the first half, winning further market share and continuing to benefit from strong customer demand in the civil aerospace market in the US, Europe and the UK. Further geographic diversification has been achieved via key aerospace contract wins in Germany and through strengthening our presence in the US space market with new key account wins. End market diversification was supported by good momentum into motorsport, industrial and electric vertical take-off and landing (\"eVTOL\") aircraft. \n   \n In UK Wire and Cable the impact of softer demand in UK construction and wholesale end markets was partially mitigated by increased exposure to major infrastructure projects. Momentum built towards the end of the period, and we expect a stronger second half performance. \n   \n With the acquisition of T.I.E. during FY23, we entered the attractive Industrial Automation end market. Since acquisition, we have invested in enhancing the commercial operation of the business, including expansion of the sales team to drive geographic diversification across the US. Whilst strike action in the automotive market moderated growth at the start of the year, a favourable mix shift supported margin improvement and operating profit performance was in line with our expectations.  \n   \n Targeted acquisitions to accelerate growth \n Two small bolt-on acquisitions were completed in the period, with Cable and Tubing Solutions  further broadening our medical offering in our German Interconnect business and supporting growth in this attractive end market; and Technisil expanding our Specialty Adhesives penetration in Germany. \n   \n The strategic acquisition of Peerless completed on 1 May. The addition of this US-based value-add aerospace fasteners business, enables us to build scale and expand our presence and capabilities in the attractive aerospace and defence end markets in the US and Europe. Supplying fasteners into the airframe of aircraft, Peerless is highly complementary to our existing Specialty Fasteners business, Clarendon, which supplies products into aircraft cabins and seats. There is no impact of Peerless in these first half results. \n   \n Building scale \n Significant investment in technology and facilities continues as the Sector finalises the integration of its three UK Wire & Cable locations into one state-of-the-art automated facility and onto a common ERP platform. In addition to delivering operational efficiencies, there is a commercial benefit from this new, integrated structure via enhanced cross-selling capabilities across previously separate sales teams. \n   \n Supporting end market penetration, we have invested in specialist sales resource in Interconnect, enabling expansion in medical, rail and defence markets, and in Specialty Adhesives to maximise long-term aerospace and defence opportunities. \n   \n Outlook \n We have made good strategic progress in Controls. Our businesses are benefiting from initiatives to capture growth in structurally growing end markets, such as medical, energy and EVs, as well as high-growth emerging markets, such as space and eVTOL. We are also benefiting from continued geographic diversification as we continue to build scale in the US and Europe. The Sector has strong momentum into the second half of the year, and will be boosted further by the addition of the high growth, high margin Peerless business. We remain very positive about its outlook. \n   \n Sector review: SEALS \n   \n The Seals Sector businesses supply a range of seals, gaskets, cylinders, components and kits used in heavy mobile machinery and a diverse range of fluid power products with Aftermarket, Original Equipment Manufacturing (OEM) and Maintenance, Repair and Overhaul (MRO) applications. \n   \n \n \n \n \n \n \n \n H1 24 \n \n \n H1 23 \n \n \n Change \n \n \n \n \n Revenue \n \n \n £241.2m \n \n \n £198.4m \n \n \n +22% \n \n \n \n \n Organic revenue growth \n \n \n +1% \n \n \n +8% \n \n \n \n \n \n \n \n Statutory operating profit \n \n \n £27.8m \n \n \n £29.3m \n \n \n (5%) \n \n \n \n \n Adjusted operating profit \n \n \n £44.3m \n \n \n £35.7m \n \n \n +24% \n \n \n \n \n Adjusted operating margin \n \n \n 18.4% \n \n \n 18.0% \n \n \n +40bps \n \n \n \n \n   \n H1 24 highlights \n \n \n \n \n • \n \n \n Organic revenue growth of 1% driven by resilient performance against backdrop of customer destocking. Signs of normalisation into the second half with typical ordering patterns starting to resume. \n \n \n \n \n • \n \n \n Adjusted operating profit increased by 24% to £44.3m, driven by operational leverage and contribution from DICSA. \n \n \n \n \n • \n \n \n Acquisition of PAR Group into R&G expanding capabilities and further diversifying UK Aftermarket's customer base and end market. \n \n \n \n \n   \n International Seals (57% of Seals Sector revenue 2 ) delivered organic growth of 1% against strong prior year comparatives; continued destocking by OEM and reseller customers; and short term market challenges in Europe. Reported revenue growth was 42%, reflecting prior year acquisitions, particularly DICSA in the second half of FY23. \n   \n 2 Including proforma revenue for PAR Group which completed after the period end. \n   \n North American Seals (43% of Seals Sector revenue) delivered organic growth of 1% and a further 6% contribution from prior year acquisitions, as strong growth in MRO mitigated continued destocking by OEM and reseller customers. \n   \n Revenue diversification driving organic growth \n In International Seals, our UK Aftermarket business, R&G benefited from diversification into product adjacencies increasing penetration across its end markets, organically and through targeted acquisitions. Our Australian Seals businesses delivered excellent growth, as its strong customer proposition drove share gains in markets benefiting from sustained infrastructure investments and continuous strong demand for the mining of the minerals required for electrification. European OEM businesses continued to be impacted by customer destocking during the first half, with signs of normalisation emerging with the resumption of typical ordering patterns in some areas. In European Aftermarket , DICSA performed in line with expectations following its acquisition in the second half of FY23 with good growth in its core stainless steel fittings that was partially offset by the impact of destocking in some channels. \n   \n In North American Seals, MRO delivered strong organic growth. We have increased our position in industrial and transportation markets through product development and geographical expansion. Prior year acquisitions also achieved strong organic growth in the period driven by cross-selling products and services. The US Aftermarket business, Hercules, delivered a resilient performance following a period of strong growth in the prior year, supported by high demand for repairs. The US OEM business was resilient in the face of continued customer destocking, as product extension and end market expansion delivered growth. There are signs of more typical customer buying patterns into the second half. \n   \n During the period, the Sector began to explore intercompany opportunities in fluid power arising from the acquisition of DICSA. Collaboration is underway between R&G and DICSA, to expand reach across their respective established core markets in the UK and Europe. In addition, DICSA and Hercules Aftermarket are working together to distribute DICSA product from the Louisville Autostore, leveraging Hercules' sales and logistics capabilities. We are in the early stages of these developments but we see exciting growth opportunities ahead. \n   \n Targeted acquisitions to accelerate growth \n R&G added two bolt-on acquisitions during the first half. Fast Gaskets, a distributor of soft gaskets and rubber sheets, is an approved supplier to the UK defence industry, and a specialist solution provider into the food & beverage and pharmaceutical & chemical end markets. Abbey Hose, a specialist hydraulic and industrial hose distributor, extends R&G's geographical reach within the UK and creates access to key infrastructure projects and customers. \n   \n We acquired UK-based PAR Group into R&G on 30 April 2024. It is a very complementary business, significantly expanding our UK Aftermarket seals & gaskets capabilities and further diversifying R&G's customer base and end market exposure. The acquisition presents strong opportunities for organic growth, synergies and cross-selling. \n   \n Building scale \n During the period, we opened our new European OEM M Seals facility in Denmark. The low-emission, state-of the-art facility creates a Nordic hub for the Sector, providing improved warehousing capabilities and a wide range of value-add services to support future growth. In UK Aftermarket , we created a National Distribution Centre in Lincoln that will act as the main stocking location for all our R&G Hydraulics businesses. We also introduced a hose assembly Centre of Excellence in Liverpool. Our scaling journey continues in Australia as we near completion of the integration of three, previously standalone, businesses to form one larger business. \n   \n In North American Seals, our continued focus on the supply chain is yielding positive results in optimising inventory levels and delivering process improvements within operations and commercial execution. Investments in seal machining, webstore enhancements and new products position the Aftermarket business well for continued growth as US infrastructure projects accelerate. \n   \n Outlook \n The Seals Sector has been resilient through challenging trading conditions, and continues to make strategic progress, strengthening its presence across attractive end markets, building cross-selling opportunities and scaling our operations. We are well positioned to benefit from the significant investments into infrastructure projects across the US and Europe. As we continue to see the resumption of more typical buying patterns across our OEM and reseller customer bases, we expect a stronger performance in the second half of the year. \n   \n SECTOR REVIEW: LIFE SCIENCES \n   \n The Life Sciences Sector sources and supplies technology driven value add solutions in the In Vitro Diagnostics (\"IVD\"), Scientific and Medtech segments of the Global Healthcare market. \n   \n \n \n \n \n \n \n \n H1 24 \n \n \n H1 23 \n \n \n Change \n \n \n \n \n Revenue \n \n \n £109.0m \n \n \n £105.6m \n \n \n +3% \n \n \n \n \n Organic revenue growth \n \n \n 5% \n \n \n 4% \n \n \n \n \n \n \n \n Statutory operating profit \n \n \n £16.9m \n \n \n £16.7m \n \n \n +1% \n \n \n \n \n Adjusted operating profit \n \n \n £21.6m \n \n \n £20.9m \n \n \n +3% \n \n \n \n \n Adjusted operating margin \n \n \n 19.8% \n \n \n 19.8% \n \n \n - \n \n \n \n \n   \n H1 24 highlights \n \n \n \n \n • \n \n \n Organic revenue growth of 5% with continued momentum led by strong performance and market share gains in Australia and Canada. \n \n \n \n \n • \n \n \n Adjusted operating profit was up 3%, with foreign exchange headwinds partially offsetting organic growth. Margins were flat year-on-year. \n \n \n \n \n • \n \n \n Significant investments in scaling to support future growth in Canada and Europe. \n \n \n \n \n   \n Revenue diversification driving organic growth \n In the first half of the year, adoption of new technology in healthcare settings and continued diversification through new product introductions have been the primary drivers of growth. We are increasingly collaborating across geographies to leverage strong supplier and product relationships from one business to bring new and improved customer offers to other regions. As we aim to scale our Scientific business, we see medium-term growth opportunities across pharmaceutical, biotech and food and beverage end markets driven respectively by development of new patient treatment modalities such as cell and gene therapy, as well as increased food production quality control regulations.   \n   \n In Canada , we have seen continued adoption and implementation of new technologies by hospitals within the urology, gynaecology and endoscopy specialties creating opportunities to broaden our product range and grow market share. IVD testing has grown in this market reflecting ongoing investment. In Australia , growth has been driven by the increased demand for genetic preconception screening supported by increased government investment and continued growth of our IVD business. Growth in allergy and autoimmunity testing has been driven by the extension of our service to existing customers through expanded offerings. In Europe , organic growth was broadly flat. Continued growth in IVD and critical care portfolios in the UK and Ireland, and tender wins in the Nordics drove good growth. This was offset by the timing of capital projects; product portfolio optimisation to phase out some lower margin products; and a supplier contract concluding during the period. \n   \n Building scale \n Following the successful integration of our Australian businesses in FY23, we have invested in scaling our Canadian business. In combining and relocating sites, and upgrading facilities across Canada, we will improve customer service; reduce shipment times; deliver operational improvements and efficiencies; and increase our access to talent. \n   \n In Europe, we completed the integration of our Nordic Life Sciences businesses enhancing our customer proposition through the expansion of products and services. \n   \n Outlook \n The outlook for the full year remains positive as we see continued opportunities in new technology adoption in Canada; expanding the array of diagnostic testing in Australia; and increased funding of capital projects in Europe. \n   \n FINANCE review \n   \n Summary income statement \n   \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n   \n \n \n \n \n   \n   \n \n \n \n \n \n Six months ended 31 March 2024 \n \n \n Six months ended 31 March 2023 \n \n \n \n \n Adjusted 1 £m \n \n \n Adjustments 1 £m \n \n \n Total £m \n \n \n Adjusted 1 £m \n \n \n Adjustments 1 £m \n \n \n Total £m \n \n \n   \n \n \n \n \n R evenue \n \n \n \n \n \n \n \n \n 638.3 \n \n \n - \n \n \n 638.3 \n \n \n 582.8 \n \n \n - \n \n \n 582.8 \n \n \n   \n \n \n \n \n Operating expenses \n \n \n \n \n \n \n \n \n (512.9) \n \n \n (37.4) \n \n \n (550.3) \n \n \n (473.1) \n \n \n (17.2) \n \n \n (490.3) \n \n \n   \n \n \n \n \n Operating profit \n \n \n \n \n \n \n \n \n 125.4 \n \n \n (37.4) \n \n \n 88.0 \n \n \n 109.7 \n \n \n (17.2) \n \n \n 92.5 \n \n \n   \n \n \n \n \n Financial expense, net \n \n \n \n \n \n \n \n \n (10.2) \n \n \n - \n \n \n (10.2) \n \n \n (11.0) \n \n \n (2.8) \n \n \n (13.8) \n \n \n   \n \n \n \n \n Profit before tax \n \n \n \n \n \n \n \n \n 115.2 \n \n \n (37.4) \n \n \n 77.8 \n \n \n 98.7 \n \n \n (20.0) \n \n \n 78.7 \n \n \n   \n \n \n \n \n Tax expense \n \n \n \n \n \n \n \n \n (27.6) \n \n \n 7.9 \n \n \n (19.7) \n \n \n (24.2) \n \n \n 5.2 \n \n \n (19.0) \n \n \n   \n \n \n \n \n Profit for the period \n \n \n \n \n \n \n \n \n 87.6 \n \n \n (29.5) \n \n \n 58.1 \n \n \n 74.5 \n \n \n (14.8) \n \n \n 59.7 \n \n \n   \n \n \n \n \n Earnings per share (p) \n \n \n \n \n \n \n \n \n   \n \n \n   \n \n \n   \n \n \n \n \n \n \n \n \n \n \n \n   \n \n \n \n \n Adjusted/Basic \n \n \n \n \n \n \n \n \n 65.1p \n \n \n (22.0p) \n \n \n 43.1p \n \n \n 59.1p \n \n \n (11.8p) \n \n \n 47.3p \n \n \n   \n \n \n \n \n   \n ¹ The Group reports under UK-adopted International Accounting Standards and references alternative performance measures where the Board believes that they help to effectively monitor the performance of the Group and support readers of the Financial Statements in drawing comparisons with past performance. Certain alternative performance measures are also relevant in calculating a meaningful element of Executive Directors' variable remuneration and our debt covenants. Alternative performance measures are not considered to be a substitute for, or superior to, IFRS measures. These are detailed in note 13 to the Condensed Consolidated Financial Statements. \n   \n Reported revenue increased by 10% to £638.3m (H1 23: £582.8m), consisting of organic growth of 5%, an 8% net contribution from acquisitions and disposals, partly offset by the adverse 3% impact from foreign exchange translation. \n   \n Adjusted operating profit increased by 14% to £125.4m (H1 23: £109.7m) as the operational leverage from increased revenue, disciplined cost management and accretive acquisitions drove a 80bps year-on-year improvement in the adjusted operating margin to 19.6% (H1 23: 18.8%). \n   \n Statutory operating profit is £88.0m. The prior year, at £92.5m, benefitted from an exceptional gain on the disposal of Hawco of £12.2m. \n   \n Adjusted profit before tax increased 17% to £115.2m (H1 23: £98.7m). Net adjusted interest expense decreased to £10.2m (H1 23: £11.0m), driven largely by the structure and mix of debt facilities. The all-in, blended cost of our borrowing facilities decreased to 5.2% (H1 23: 5.5%). Statutory profit before tax is £77.8m, with prior year of £78.7m benefiting from the exceptional gain on the disposal of Hawco.  \n   \n The Group's adjusted effective rate of tax on adjusted profit before tax for the period was 24.0% (FY23: 24.0%), comparable with the year ended 30 September 2023. \n   \n Adjusted earnings per share increased by 10% to 65.1p (H1 23: 59.1p). Basic earnings per share is 43.1p, with prior year of 47.3p benefiting from 9.7p due to the exceptional gain on the disposal of Hawco. As at 31 March 2024, the average number of ordinary shares (which includes any potentially dilutive shares) was 134,328,842 (H1 23: 125,927,286) and the weighted average number of ordinary shares in issue was 134,009,865 (H1 23: 125,360,523). \n   \n Cash management \n Free cash flow increased by 28% to £66.3m (H1 23: £51.8m). Statutory cash flow from operating activities increased by 20% to £77.7m (H1 23: £64.7m). \n   \n \n \n \n \n \n \n \n \n \n \n \n \n \n Six months ended \n 31 March \n 2024 \n \n \n Six months ended \n 31 March \n 2023 \n \n \n \n \n Funds flow \n \n \n \n \n \n £m \n \n \n £m \n \n \n \n \n Adjusted operating profit \n \n \n \n \n \n 125.4 \n \n \n 109.7 \n \n \n \n \n Depreciation and other non-cash items \n \n \n \n \n \n 15.8 \n \n \n 15.3 \n \n \n \n \n Working capital movement \n \n \n \n \n \n (17.1) \n \n \n (22.8) \n \n \n \n \n Interest paid, net (excluding borrowing fees) \n \n \n \n \n \n (8.2) \n \n \n (9.8) \n \n \n \n \n Tax paid \n \n \n \n \n \n (33.3) \n \n \n (22.2) \n \n \n \n \n Capital expenditure, net of disposal proceeds \n \n \n \n \n \n (4.2) \n \n \n (9.5) \n \n \n \n \n Lease repayments \n \n \n \n \n \n (9.9) \n \n \n (7.0) \n \n \n \n \n Notional purchase of own shares on exercise of options \n \n \n \n \n \n (2.2) \n \n \n (1.9) \n \n \n \n \n Free cash flow \n \n \n \n \n \n 66.3 \n \n \n 51.8 \n \n \n \n \n Acquisition and disposals (net of cash acquired/disposed) including acquisition expenses and acquisition related deferred (payments)/receipts \n \n \n    \n \n \n (21.6) \n \n \n (75.9) \n \n \n \n \n Proceeds from issue of share capital (net of fees) \n \n \n \n \n \n - \n \n \n 232.5 \n \n \n \n \n Dividends paid to shareholders and minority interests \n \n \n \n \n \n (53.8) \n \n \n (48.7) \n \n \n \n \n Foreign exchange \n \n \n \n \n \n 5.2 \n \n \n 15.2 \n \n \n \n \n Net funds flow \n \n \n \n \n \n (3.9) \n \n \n 174.9 \n \n \n \n \n Net debt \n \n \n \n \n \n (258.6) \n \n \n (154.0) \n \n \n \n \n   \n Working capital increased by £17.1m, driven by an increase in receivables of £16.4m, reflective of the revenue growth during the period.  \n   \n Depreciation and other non-cash items includes £15.6m (H1 23: £13.4m) of depreciation and amortisation of tangible, intangible and right-of-use assets and £0.2m (H1 23: £1.9m) of non-cash items, primarily share-based payments expense largely offset by profit on disposal of tangible assets. \n   \n Interest payments decreased by £1.6m to £8.2m (H1 23: £9.8m) driven largely by the structure and mix of debt facilities, in line with the movement of interest in the income statement. Tax payments in the first half of the year were higher by £11.1m at £33.3m (H1 23: £22.2m) due to the increase in the UK corporation tax rate and acquisitions made in 2023. \n   \n Net capital expenditure was £5.3m lower than prior year, benefiting from £5.5m of proceeds from the disposal of property, plant and equipment. The Group funded the Company's Employee Benefit Trust with £2.2m (H1 23: £1.9m) in connection with the Company's long term incentive plan. \n   \n The Group generated free cash flow of £66.3m (H1 23: £51.8m) a very strong 28% increase on the prior year, resulting in free cash flow conversion of 76% (H1 23: 70%). \n   \n Net total acquisition expenditure of £21.6m (H1 23: £75.9m) comprises the cash spend on four bolt-on acquisitions (£7.2m), acquisition fees (£2.0m), and acquisition related deferred payments (£13.4m) which largely relate to WCW deferred remuneration, partially offset by the deferred consideration received in respect of the disposal of Hawco (£1.0m). \n   \n Dividends of £53.8m (H1 23: £48.7m) were paid to ordinary and minority interest shareholders.  \n   \n Net debt \n The Group has a multi-currency Revolving Credit Facility agreement (\"RCF\") with an aggregate principal amount of £555.0m which was originally entered into on 17 July 2023. The RCF is due to expire in July 2028 with an option to extend for two further 12-month periods. At 31 March 2024, the Group had utilised £108.7m of the RCF (2023: £41.8m), comprising £30.0m of the GBP RCF and £78.7m (€92.0m) of EUR RCF. £446.3m of the revolving facility remains undrawn. \n   \n The Group issued private placement (\"PP\") notes for an aggregate principal amount of £213.5m (€250.0m) on 20 March 2024. The PP notes have maturities of 7 years (€75m), 10 years (€100m) and 12 years (€75m). \n   \n The Group continues to maintain a robust balance sheet with net debt (excluding IFRS 16 liabilities) of £258.6m (H1 23: £154.0m) comprised of borrowings of £318.1m (H1 23: £226.1m), less cash funds of £59.5m (H1 23: £72.1m). This represented leverage of 0.9x (H1 23: 0.7x) against a Board policy of below 2.0x and lending covenants of below 3.5x. The Group maintains strong liquidity, with period end headroom (comprised of undrawn committed facilities and cash funds) of £506m (H1 23: £390m). \n   \n The table below outlines the composition of the Group's net debt at 31 March 2024: \n   \n \n \n \n \n Type \n \n \n Currency \n \n \n Amount \n \n \n GBP equivalent \n \n \n Interest rate exposure \n \n \n \n \n PP 7 year maturity \n \n \n EUR \n \n \n €75.0m \n \n \n £64.1m \n \n \n Fixed 4.18% \n \n \n \n \n PP 10 year maturity \n \n \n EUR \n \n \n €100.0m \n \n \n £85.5m \n \n \n Fixed 4.27% \n \n \n \n \n PP 12 year maturity \n \n \n EUR \n \n \n €75.0m \n \n \n £64.1m \n \n \n Fixed 4.38% \n \n \n \n \n RCF \n \n \n EUR \n \n \n €92.0m \n \n \n £78.7m \n \n \n Floating \n \n \n \n \n RCF \n \n \n GBP \n \n \n £30.0m \n \n \n £30.0m \n \n \n Floating \n \n \n \n \n Capitalised debt fees net of accrued interest \n \n \n (£4.3m) \n \n \n \n \n \n \n \n \n \n \n \n \n Gross debt drawn at 31 March 2024 \n \n \n £318.1m \n \n \n \n \n \n \n \n Cash & equivalents at period end \n \n \n (£59.5m) \n \n \n \n \n \n \n \n Net debt at 31 March 2024 \n \n \n £258.6m \n \n \n   \n \n \n \n \n   \n Defined Benefit Pension \n Both the UK defined benefit scheme and the Kubo contribution scheme are accounted for in accordance with IAS 19 (revised). \n   \n The Group maintains a legacy closed defined benefit pension scheme in the UK. In the period, the Group funded this scheme with cash contributions of £0.4m (H1 23: £0.3m). \n   \n On 26 March 2024, the Trustees completed a buy-in of the remaining pensioner liabilities in the Scheme with Just Retirement Limited. The Scheme paid £25.1m to Just Retirement Limited on 26 March 2024 to fund 100% of the buy-in premium. As at 31 March 2024, the Group's financial statements include a net asset of £1.4m (30 September 2023: £6.8m) in respect of the Group's UK pension scheme. As at 31 March 2024, 95% of the scheme assets are concentrated in the buy-in policy and we expect to make no further funding payments. \n   \n In Switzerland, local law requires our Kubo business to provide a contribution-based pension for all employees, which is funded by employer and employee contributions. The pension deficit in the Swiss scheme was £0.3m (30 September 2023: £0.3m). The cash contribution to the scheme was £0.2m (H1 23: £0.2m). \n   \n Exchange rates \n A significant proportion of the Group's revenues (ca. 80%) are derived from businesses located outside the UK, principally in the US, Canada, Australia and Europe. Compared with the first half of last year, the average Sterling exchange rate is stronger against most of the major currencies in which the Group operates. The impact from translating the results of the Group's overseas businesses into UK sterling has led to a decrease in Group revenues of £20.0m; a decrease in the Group's adjusted operating profit of £4.5m; and a decrease in net debt of £1.3m, compared with the same period last year. \n   \n Going concern \n The Directors have assessed the relevant factors surrounding going concern. \n   \n The Group continues to operate against a backdrop of macroeconomic disruption, including widespread global inflation and rising interest rates. Accordingly, the Directors have again considered a comprehensive going concern view. The Group has carried out an assessment of its projected trading for the 18-month period through to the year ending 30 September 2025. This assessment incorporated a severe but plausible downside scenario and the cash consideration for Peerless and PAR Group after the period end, which demonstrates that the Group has sufficient liquidity, resources and covenant headroom to continue in operation for the foreseeable future. \n   \n The Group has considerable financial resources, together with a broad spread of customers and suppliers across different geographic areas and Sectors, often secured with longer term agreements. As a consequence, the Directors believe that the Group is well placed to manage its business risks successfully. The Directors confirm there are no material uncertainties which may cast significant doubt on the Group's ability to continue as a going concern and these condensed consolidated financial statements have therefore been prepared on a going concern basis. \n   \n RISKS AND UNCERTAINTIES \n   \n Effective risk management is a key component of the discipline that underpins sustainable quality compounding. \n   \n The Group's decentralised operating model helps mitigate the potential impact of our principal risks. The principal risks which have the potential to be material to the performance, position or future prospects of the Group are described in more detail in pages 44-48 of the 2023 Annual Report & Accounts. This includes more detail on our overall approach to risk management as well as the specific mitigation actions in place for our principal risks. \n   \n The principal risks are summarised below (not ranked): \n \n \n \n \n • \n \n \n Unsuccessful acquisition : the Group may overpay for a target; the acquired business may experience limited growth post-acquisition; loss of key customers or suppliers post integration; potential cultural misfit. \n \n \n \n \n • \n \n \n Failure to attract retain and develop talent : the loss of key personnel can have an impact on performance for a limited time period; not having the right talent or diversity at all levels of the organisation to deliver our strategy, resulting in reduced financial performance. \n \n \n \n \n • \n \n \n Cyber attack : any disruption or denial of service may delay or impact decision-making if reliable data is unavailable; poor information handling or interruption of business may also lead to reduced service to customers; unintended actions of employees caused by a cyber attack may also lead to disruption, including fraud. \n \n \n \n \n • \n \n \n Supply chain disruption : the risk of manufacturing lead times increasing as a result of supply chain shortages or supply chain partners not operating to the same ethical standards as Diploma. \n \n \n \n \n • \n \n \n Loss of key supplier : the risk that a key supplier revokes a supply agreement and accesses the market through a competitor or chooses to go direct to market rather than via a distributor. \n \n \n \n \n • \n \n \n Climate - max legislation : the risk of increasing environmental legislation that adds cost or complexity to products and services and/or renders some products obsolete. \n \n \n \n \n • \n \n \n Prolonged market downturn : adverse changes in the major markets that the businesses operate in could result in slowing revenue growth due to reduced or delayed demand for products and services, or margin pressures due to increased competition. \n \n \n \n \n • \n \n \n Geopolitical trade issues : interruption of trade agreements; change of trade or tariff relationships amongst countries in which we operate; Government budget spending and political elections. \n \n \n \n \n   \n The Directors confirm that the principal risks and uncertainties and the processes for managing them have not changed materially since the publication of the 2023 Annual Report & Accounts and that they remain relevant for the second half of the financial year. \n   \n Chris Davies \n Chief Financial Officer                                                                                                        13 May 2024        \n   \n   \n Responsibility Statement of the Directors in respect of the Half Year Report 2024 \n   \n The directors confirm that Condensed Consolidated Financial Statements have been prepared in accordance with UK adopted International Accounting Standard 34, 'Interim Financial Reporting' and the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority and that the interim management report includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8, namely: \n \n \n \n \n • \n \n \n an indication of important events that have occurred during the first six months and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and \n \n \n \n \n • \n \n \n material related-party transactions in the first six months and any material changes in the related-party transactions described in the last annual report. \n \n \n \n \n   \n The Directors of Diploma PLC and their respective responsibilities are listed in the Annual Report & Accounts for 2023 and on the Company's website at www.diplomaplc.com . \n   \n \n \n \n \n By Order of the Board \n \n \n   \n \n \n \n \n   \n \n \n   \n \n \n \n \n JD Thomson \n \n \n C Davies \n \n \n \n \n Chief Executive Officer \n \n \n Chief Financial Officer \n \n \n \n \n 13 May 2024 \n \n \n 13 May 2024 \n \n \n \n \n   \n Independent review report to Diploma PLC \n Report on the condensed consolidated interim financial statements \n Our conclusion \n We have reviewed Diploma PLC's condensed consolidated interim financial statements (the \"interim financial statements\") in the Half Year Report 2024 of Diploma PLC for the 6-month period ended 31 March 2024 (the \"period\"). \n Based on our review, nothing has come to our attention that causes us to believe that the interim financial statements are not prepared, in all material respects, in accordance with UK adopted International Accounting Standard 34,''Interim Financial Reporting'' and the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority. \n The interim financial statements comprise: \n \n \n \n \n • \n \n \n the Condensed Consolidated Statement of Financial Position as at 31 March 2024; \n \n \n \n \n • \n \n \n the Condensed Consolidated Income Statement and Condensed Consolidated Statement of Comprehensive Income for the period then ended; \n \n \n \n \n • \n \n \n the Condensed Consolidated Cash Flow Statement for the period then ended; \n \n \n \n \n • \n \n \n the Condensed Consolidated Statement of Changes in Equity for the period then ended; and \n \n \n \n \n • \n \n \n the explanatory notes to the interim financial statements. \n \n \n \n \n The interim financial statements included in the Half Year Report 2024 of Diploma PLC have been prepared in accordance with UK adopted International Accounting Standard 34,''Interim Financial Reporting'' and the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority. \n Basis for conclusion \n We conducted our review in accordance with International Standard on Review Engagements (UK) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Financial Reporting Council for use in the United Kingdom (\"ISRE (UK) 2410\"). A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. \n A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and, consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. \n We have read the other information contained in the Half Year Report 2024 and considered whether it contains any apparent misstatements or material inconsistencies with the information in the interim financial statements. \n Conclusions relating to going concern \n Based on our review procedures, which are less extensive than those performed in an audit as described in the Basis for conclusion section of this report, nothing has come to our attention to suggest that the directors have inappropriately adopted the going concern basis of accounting or that the directors have identified material uncertainties relating to going concern that are not appropriately disclosed. This conclusion is based on the review procedures performed in accordance with ISRE (UK) 2410. However, future events or conditions may cause the group to cease to continue as a going concern. \n Responsibilities for the interim financial statements and the review \n Our responsibilities and those of the directors \n The Half Year Report 2024, including the interim financial statements, is the responsibility of, and has been approved by the directors. The directors are responsible for preparing the Half Year Report 2024 in accordance with the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority. In preparing the Half Year Report 2024, including the interim financial statements, the directors are responsible for assessing the group's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or to cease operations, or have no realistic alternative but to do so. \n Our responsibility is to express a conclusion on the interim financial statements in the Half Year Report 2024 based on our review. Our conclusion, including our Conclusions relating to going concern, is based on procedures that are less extensive than audit procedures, as described in the Basis for conclusion paragraph of this report. This report, including the conclusion, has been prepared for and only for the company for the purpose of complying with the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority and for no other purpose. We do not, in giving this conclusion, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing. \n PricewaterhouseCoopers LLP \n Chartered Accountants \n London \n 13 May 2024 \n   \n Condensed Consolidated Income Statement \n For the six months ended 31 March 2024 \n   \n \n \n \n \n \n \n \n \n \n \n \n \n \n Unaudited \n \n \n Unaudited \n \n \n Audited \n \n \n \n \n \n \n \n \n \n \n \n \n \n Six months ended 31 Mar 2024 \n \n \n Six months ended 31 Mar 2023 \n \n \n Year ended 30 Sep 2023 \n \n \n \n \n \n \n \n \n \n \n \n \n \n Adjusted 1 \n \n \n Adjust- \n ments 1 \n \n \n Total \n \n \n Adjusted 1 \n \n \n Adjust- \n ments 1 \n \n \n Total \n \n \n Total \n \n \n \n \n \n \n \n \n \n \n Note \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n \n \n R evenue \n \n \n \n \n \n 3 \n \n \n 638.3 \n \n \n - \n \n \n 638.3 \n \n \n 582.8 \n \n \n - \n \n \n 582.8 \n \n \n 1,200.3 \n \n \n \n \n Operating expenses \n \n \n \n \n \n 2 \n \n \n (512.9) \n \n \n (37.4) \n \n \n (550.3) \n \n \n (473.1) \n \n \n (17.2) \n \n \n (490.3) \n \n \n (1,017.0) \n \n \n \n \n Operating profit \n \n \n \n \n \n \n \n \n 125.4 \n \n \n (37.4) \n \n \n 88.0 \n \n \n 109.7 \n \n \n (17.2) \n \n \n 92.5 \n \n \n 183.3 \n \n \n \n \n Financial expense, net \n \n \n \n \n \n 4 \n \n \n (10.2) \n \n \n - \n \n \n (10.2) \n \n \n (11.0) \n \n \n (2.8) \n \n \n (13.8) \n \n \n (27.7) \n \n \n \n \n Profit before tax \n \n \n \n \n \n \n \n \n 115.2 \n \n \n (37.4) \n \n \n 77.8 \n \n \n 98.7 \n \n \n (20.0) \n \n \n 78.7 \n \n \n 155.6 \n \n \n \n \n Tax expense \n \n \n \n \n \n 5 \n \n \n (27.6) \n \n \n 7.9 \n \n \n (19.7) \n \n \n (24.2) \n \n \n 5.2 \n \n \n (19.0) \n \n \n (37.3) \n \n \n \n \n Profit for the period \n \n \n \n \n \n \n \n \n 87.6 \n \n \n (29.5) \n \n \n 58.1 \n \n \n 74.5 \n \n \n (14.8) \n \n \n 59.7 \n \n \n 118.3 \n \n \n \n \n Attributable to: \n \n \n \n \n \n \n \n \n   \n \n \n   \n \n \n   \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Shareholders of the Company \n \n \n \n \n \n 6 \n \n \n 87.2 \n \n \n (29.5) \n \n \n 57.7 \n \n \n 74.1 \n \n \n (14.8) \n \n \n 59.3 \n \n \n 117.7 \n \n \n \n \n Minority interests \n \n \n \n \n \n \n \n \n 0.4 \n \n \n - \n \n \n 0.4 \n \n \n 0.4 \n \n \n - \n \n \n 0.4 \n \n \n 0.6 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 87.6 \n \n \n (29.5) \n \n \n 58.1 \n \n \n 74.5 \n \n \n (14.8) \n \n \n 59.7 \n \n \n 118.3 \n \n \n \n \n Earnings per share (p) \n \n \n \n \n \n \n \n \n   \n \n \n   \n \n \n   \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Adjusted / Basic \n \n \n \n \n \n 6 \n \n \n 65.1p \n \n \n (22.0p) \n \n \n 43.1p \n \n \n 59.1p \n \n \n (11.8p) \n \n \n 47.3p \n \n \n 90.8p \n \n \n \n \n Adjusted / Diluted  \n \n \n \n \n \n 6 \n \n \n 64.9p \n \n \n (21.9p) \n \n \n 43.0p \n \n \n 58.8p \n \n \n (11.7p) \n \n \n 47.1p \n \n \n 90.4p \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n ¹ Adjusted figures exclude certain items as set out and explained in the Financial Review and as detailed in Notes 2, 3, 4, 5 and 6. All amounts relate to continuing operations. \n   \n Condensed Consolidated Statement of Comprehensive Income \n For the six months ended 31 March 2024 \n   \n \n \n \n \n \n \n \n \n \n \n \n \n \n Unaudited \n 31 Mar \n 2024 \n \n \n Unaudited \n 31 Mar \n 2023 \n \n \n Audited \n 30 Sep \n 2023 \n \n \n \n \n \n \n \n \n \n \n \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n \n \n Profit for the period \n \n \n   \n \n \n 58.1 \n \n \n 59.7 \n \n \n 118.3 \n \n \n \n \n   \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n \n \n Items that will not be reclassified to the Consolidated Income Statement \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n \n \n      Actuarial (loss)/gain on the defined benefit pension schemes \n \n \n \n \n \n (6.0) \n \n \n 2.0 \n \n \n (0.9)  \n \n \n \n \n      Deferred tax on items that will not be reclassified \n \n \n \n \n \n 1.5 \n \n \n (0.6) \n \n \n 0.2 \n \n \n \n \n   \n \n \n \n \n \n (4.5) \n \n \n 1.4 \n \n \n (0.7) \n \n \n \n \n   \n \n \n   \n \n \n \n \n \n \n \n \n \n \n Items that may be reclassified to the Consolidated Income Statement \n \n \n   \n \n \n \n \n \n \n \n \n \n \n      Exchange differences on translation of foreign operations \n \n \n \n \n \n (21.0) \n \n \n (49.2) \n \n \n (46.3) \n \n \n \n \n      Net investment hedge - net loss \n \n \n \n \n \n (0.2) \n \n \n - \n \n \n - \n \n \n \n \n      (Losses)/gains on fair value of cash flow hedges \n \n \n \n \n \n \n \n \n (0.3) \n \n \n (0.3) \n \n \n 1.8 \n \n \n \n \n Net changes to fair value of cash flow hedges transferred to the Consolidated Income Statement \n \n \n \n \n \n \n \n \n   \n (2.1) \n \n \n   \n (0.7) \n \n \n   \n (3.8) \n \n \n \n \n Deferred tax on items that may be reclassified \n \n \n \n \n \n \n \n \n 0.6 \n \n \n 0.2 \n \n \n 0.5 \n \n \n \n \n   \n \n \n \n \n \n \n \n \n (23.0) \n \n \n (50.0) \n \n \n (47.8) \n \n \n \n \n Total Comprehensive Income for the period \n \n \n \n \n \n 30.6 \n \n \n 11.1 \n \n \n 69.8 \n \n \n \n \n   \n Attributable to: \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n \n \n      Shareholders of the Company \n \n \n \n \n \n \n \n \n 30.2 \n \n \n 10.7 \n \n \n 69.3 \n \n \n \n \n      Minority interests \n \n \n \n \n \n \n \n \n 0.4 \n \n \n 0.4 \n \n \n 0.5 \n \n \n \n \n \n \n \n \n \n \n \n \n \n 30.6 \n \n \n 11.1 \n \n \n  69.8 \n \n \n \n \n \n \n \n \n \n \n \n \n \n   \n Condensed Consolidated Statement of C hanges in Equity \n For the six months ended 31 March 2024 \n   \n \n \n \n \n   \n \n \n Share capital \n \n \n Share premium \n \n \n Transl-ation reserve \n \n \n Hedging reserve \n \n \n Retained earnings \n \n \n Share-holders' equity \n \n \n Minority \n interests \n \n \n Total \n equity \n \n \n \n \n   \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n \n \n At 1 October 2022 (audited) \n \n \n 6.3 \n \n \n 188.6 \n \n \n 88.8 \n \n \n 3.2 \n \n \n 375.1 \n \n \n 662.0 \n \n \n 6.2 \n \n \n 668.2 \n \n \n \n \n Total comprehensive income \n \n \n - \n \n \n - \n \n \n (49.2) \n \n \n (0.8) \n \n \n 60.7 \n \n \n 10.7 \n \n \n 0.4 \n \n \n 11.1 \n \n \n \n \n Issue of share capital \n \n \n 0.5 \n \n \n 231.6 \n \n \n - \n \n \n - \n \n \n - \n \n \n 232.1 \n \n \n - \n \n \n 232.1 \n \n \n \n \n Share-based payments \n \n \n - \n \n \n - \n \n \n - \n \n \n - \n \n \n 2.2 \n \n \n 2.2 \n \n \n - \n \n \n 2.2 \n \n \n \n \n Notional purchase of own shares \n \n \n - \n \n \n - \n \n \n - \n \n \n - \n \n \n (1.9) \n \n \n (1.9) \n \n \n - \n \n \n (1.9) \n \n \n \n \n Dividends \n \n \n - \n \n \n - \n \n \n - \n \n \n - \n \n \n (48.4) \n \n \n (48.4) \n \n \n (0.3) \n \n \n (48.7) \n \n \n \n \n At 31 March 2023 (unaudited) \n \n \n 6.8 \n \n \n 420.2 \n \n \n 39.6 \n \n \n 2.4 \n \n \n 387.7 \n \n \n 856.7 \n \n \n          6.3 \n \n \n 863.0 \n \n \n \n \n Total comprehensive income \n \n \n - \n \n \n - \n \n \n 2.9 \n \n \n (0.7) \n \n \n 56.4 \n \n \n 58.6  \n \n \n 0.1 \n \n \n 58.7 \n \n \n \n \n Share-based payments \n \n \n - \n \n \n - \n \n \n -  \n \n \n -  \n \n \n 1.9 \n \n \n 1.9  \n \n \n - \n \n \n 1.9 \n \n \n \n \n Tax on items recognised directly in equity \n \n \n - \n \n \n - \n \n \n -  \n \n \n -  \n \n \n 0.5 \n \n \n 0.5  \n \n \n - \n \n \n 0.5 \n \n \n \n \n Dividends \n \n \n - \n \n \n - \n \n \n -  \n \n \n -  \n \n \n (22.1) \n \n \n (22.1) \n \n \n - \n \n \n (22.1) \n \n \n \n \n At 30 September 2023 (audited) \n \n \n 6.8 \n \n \n 420.2 \n \n \n 42.5 \n \n \n 1.7 \n \n \n 424.4 \n \n \n 895.6 \n \n \n 6.4 \n \n \n 902.0 \n \n \n \n \n Total comprehensive income \n \n \n - \n \n \n - \n \n \n (21.2) \n \n \n (1.8) \n \n \n 53.2 \n \n \n 30.2 \n \n \n 0.4 \n \n \n 30.6 \n \n \n \n \n Share-based payments \n \n \n - \n \n \n - \n \n \n - \n \n \n - \n \n \n 3.5 \n \n \n 3.5 \n \n \n - \n \n \n   3.5 \n \n \n \n \n Tax on items recognised directly in equity \n \n \n - \n \n \n - \n \n \n - \n \n \n - \n \n \n 0.5 \n \n \n 0.5 \n \n \n - \n \n \n   0.5 \n \n \n \n \n Notional purchase of own shares \n \n \n - \n \n \n             - \n \n \n - \n \n \n - \n \n \n (2.2) \n \n \n (2.2) \n \n \n - \n \n \n  (2.2) \n \n \n \n \n Dividends \n \n \n - \n \n \n - \n \n \n - \n \n \n - \n \n \n (53.6) \n \n \n (53.6) \n \n \n (0.2) \n \n \n (53.8) \n \n \n \n \n At 31 March 2024 (unaudited) \n \n \n 6.8 \n \n \n 420.2 \n \n \n 21.3 \n \n \n (0.1) \n \n \n 425.8 \n \n \n 874.0 \n \n \n 6.6 \n \n \n 880.6 \n \n \n \n \n   \n Condensed Consolidated Statement of Financial Position \n As at 31 March 2024 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Unaudited \n 31 Mar 2024 \n \n \n Unaudited \n 31 Mar 2023 \n \n \n Audited 30 Sep 2023 \n \n \n \n \n \n \n \n \n \n \n Note \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n \n \n Non-current assets \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Goodwill \n \n \n \n \n \n \n \n \n 9 \n \n \n 432.7 \n \n \n 374.6 \n \n \n 439.1 \n \n \n \n \n Acquisition intangible assets \n \n \n \n \n \n \n \n \n 9 \n \n \n 486.9 \n \n \n 451.5 \n \n \n 520.1 \n \n \n \n \n Other intangible assets \n \n \n \n \n \n \n \n \n \n \n \n 3.5 \n \n \n 4.1 \n \n \n 4.2 \n \n \n \n \n Property, plant and equipment \n \n \n \n \n \n \n \n \n \n \n \n 59.0 \n \n \n 49.3 \n \n \n 59.2 \n \n \n \n \n Leases - right-of-use of assets \n \n \n \n \n \n \n \n \n \n \n \n 77.6 \n \n \n 54.6 \n \n \n 71.5 \n \n \n \n \n Retirement benefit assets \n \n \n \n \n \n \n \n \n \n \n \n 1.4 \n \n \n 8.8 \n \n \n 6.8 \n \n \n \n \n Deferred tax assets \n \n \n \n \n \n \n \n \n \n \n \n 0.3 \n \n \n 0.4 \n \n \n 0.2 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 1,061.4 \n \n \n 943.3 \n \n \n 1,101.1 \n \n \n \n \n Current assets \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Inventories \n \n \n \n \n \n \n \n \n \n \n \n 223.9 \n \n \n 216.3 \n \n \n 232.7 \n \n \n \n \n Trade and other receivables \n \n \n \n \n \n \n \n \n \n \n \n 201.3 \n \n \n 173.7 \n \n \n 193.1 \n \n \n \n \n Cash and cash equivalents \n \n \n \n \n \n \n \n \n 8 \n \n \n 59.5 \n \n \n 72.1 \n \n \n 62.4 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 484.7 \n \n \n 462.1 \n \n \n 488.2 \n \n \n \n \n Current liabilities \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Borrowings \n \n \n \n \n \n \n \n \n 8 \n \n \n -   \n \n \n (29.1)   \n \n \n (0.3) \n \n \n \n \n Trade and other payables \n \n \n \n \n \n \n \n \n \n \n \n    (180.2) \n \n \n    (180.2) \n \n \n (191.9) \n \n \n \n \n Current tax liabilities \n \n \n \n \n \n \n \n \n \n \n \n (5.9) \n \n \n (11.6) \n \n \n (16.6) \n \n \n \n \n Other liabilities \n \n \n \n \n \n \n \n \n \n \n \n (13.7) \n \n \n (14.4) \n \n \n (12.7) \n \n \n \n \n Lease liabilities \n \n \n \n \n \n \n \n \n \n \n \n (14.2) \n \n \n (12.3) \n \n \n (15.0) \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n (214.0) \n \n \n (247.6) \n \n \n (236.5) \n \n \n \n \n Net current assets \n \n \n \n \n \n \n \n \n \n \n \n 270.7 \n \n \n 214.5 \n \n \n 251.7 \n \n \n \n \n Total assets less current liabilities \n \n \n \n \n \n \n \n \n 1,332.1 \n \n \n 1,157.8 \n \n \n 1,352.8 \n \n \n \n \n Non-current liabilities \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Borrowings \n \n \n \n \n \n \n \n \n 8 \n \n \n (318.1) \n \n \n (197.0) \n \n \n (316.8) \n \n \n \n \n Lease liabilities \n \n \n \n \n \n \n \n \n \n \n \n (70.0) \n \n \n (49.3) \n \n \n (65.2) \n \n \n \n \n Other liabilities \n \n \n \n \n \n \n \n \n \n \n \n (9.0) \n \n \n (11.4) \n \n \n (9.9) \n \n \n \n \n Retirement benefit obligations \n \n \n \n \n \n \n \n \n \n \n \n (0.3) \n \n \n - \n \n \n (0.3) \n \n \n \n \n Deferred tax liabilities \n \n \n \n \n \n \n \n \n \n \n \n (54.1) \n \n \n (37.1) \n \n \n (58.6) \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n (451.5) \n \n \n (294.8) \n \n \n (450.8) \n \n \n \n \n Net assets \n \n \n \n \n \n \n \n \n \n \n \n 880.6 \n \n \n 863.0 \n \n \n 902.0 \n \n \n \n \n   \n Equity \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Share capital \n \n \n \n \n \n \n \n \n \n \n \n 6.8 \n \n \n 6.8 \n \n \n 6.8 \n \n \n \n \n Share premium \n \n \n \n \n \n \n \n \n \n \n \n 420.2 \n \n \n 420.2 \n \n \n 420.2 \n \n \n \n \n Translation reserve \n \n \n \n \n \n \n \n \n \n \n \n 21.3 \n \n \n 39.6 \n \n \n 42.5 \n \n \n \n \n Hedging reserve \n \n \n \n \n \n \n \n \n \n \n \n (0.1) \n \n \n 2.4 \n \n \n           1.7 \n \n \n \n \n Retained earnings \n \n \n \n \n \n \n \n \n \n \n \n 425.8 \n \n \n 387.7 \n \n \n 424.4 \n \n \n \n \n Total shareholders' equity \n \n \n \n \n \n \n \n \n \n \n \n 874.0 \n \n \n 856.7 \n \n \n 895.6 \n \n \n \n \n Minority interests \n \n \n \n \n \n \n \n \n \n \n \n 6.6 \n \n \n 6.3 \n \n \n 6.4 \n \n \n \n \n Total equity \n \n \n \n \n \n \n \n \n \n \n \n 880.6 \n \n \n 863.0 \n \n \n 902.0 \n \n \n \n \n   \n Condensed Consolidated Cash Flow Statement \n For the six months ended 31 March 2024 \n \n \n \n \n   \n   \n \n \n \n \n \n Unaudited 31 Mar 2024 \n \n \n Unaudited 31 Mar 2023 \n \n \n Audited 30 Sep 2023 \n \n \n \n \n \n \n \n Note \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n \n \n Cash flow from operating activities \n \n \n 7 \n \n \n           122.1 \n \n \n 98.2 \n \n \n 257.3 \n \n \n \n \n Interest paid, net (including borrowing fees) \n \n \n \n \n \n (11.1) \n \n \n (11.3) \n \n \n (26.7) \n \n \n \n \n Tax paid \n \n \n \n \n \n (33.3) \n \n \n (22.2) \n \n \n (41.4) \n \n \n \n \n Net cash inflow from operating activities \n \n \n \n \n \n 77.7 \n \n \n 64.7 \n \n \n 189.2 \n \n \n \n \n Cash flow from investing activities \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Acquisition of businesses (net of cash acquired) \n \n \n    \n \n \n (7.2) \n \n \n (85.4) \n \n \n (258.5) \n \n \n \n \n Acquisition related deferred payments/receipts, net \n \n \n \n \n \n (12.4) \n \n \n (8.0) \n \n \n (12.3) \n \n \n \n \n Proceeds from sale of business (net of cash disposed) \n \n \n \n \n \n - \n \n \n 21.5 \n \n \n 21.5 \n \n \n \n \n Purchase of property, plant and equipment \n \n \n \n \n \n (9.4) \n \n \n (9.4) \n \n \n (21.6) \n \n \n \n \n Purchase of other intangible assets \n \n \n \n \n \n (0.3) \n \n \n (0.8) \n \n \n (1.5) \n \n \n \n \n Proceeds from sale of property, plant and equipment \n \n \n \n \n \n 5.5 \n \n \n 0.7 \n \n \n 1.5 \n \n \n \n \n Net cash used in investing activities \n \n \n \n \n \n (23.8) \n \n \n (81.4) \n \n \n (270.9) \n \n \n \n \n Cash flow from financing activities \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Proceeds from issue of share capital \n \n \n \n \n \n - \n \n \n 236.1 \n \n \n 236.1 \n \n \n \n \n Share issue costs \n \n \n \n \n \n - \n \n \n (3.6) \n \n \n (4.2) \n \n \n \n \n Dividends paid to shareholders \n \n \n 11 \n \n \n (53.6) \n \n \n (48.4) \n \n \n (70.5) \n \n \n \n \n Dividends paid to minority interests \n \n \n \n \n \n (0.2) \n \n \n (0.3) \n \n \n (0.3) \n \n \n \n \n Notional purchase of own shares on exercise of options \n \n \n \n \n \n (2.2) \n \n \n (1.9) \n \n \n (1.9) \n \n \n \n \n Proceeds from borrowings \n \n \n \n \n \n 213.5 \n \n \n 45.3 \n \n \n 579.5 \n \n \n \n \n Repayment of borrowings \n \n \n \n \n \n (205.6) \n \n \n (171.6) \n \n \n (617.3) \n \n \n \n \n Principal elements of lease payments \n \n \n \n \n \n (7.9) \n \n \n (6.9) \n \n \n (13.9) \n \n \n \n \n Net cash (outflow)/inflow from financing activities \n \n \n \n \n \n (56.0) \n \n \n 48.7 \n \n \n 107.5 \n \n \n \n \n Net (decrease)/increase in cash and cash equivalents                                                 \n \n \n 8 \n \n \n (2.1) \n \n \n 32.0 \n \n \n 25.8 \n \n \n \n \n Cash and cash equivalents at beginning of period \n \n \n \n \n \n 62.4 \n \n \n 41.7 \n \n \n 41.7 \n \n \n \n \n Effect of exchange rates on cash and cash equivalents \n \n \n \n \n \n (0.8) \n \n \n (1.6) \n \n \n (5.1) \n \n \n \n \n Cash and cash equivalents at end of period \n \n \n 8 \n \n \n 59.5 \n \n \n 72.1 \n \n \n 62.4 \n \n \n \n \n   \n   \n Notes to the Condensed Consolidated Financial Statements \n For the six months ended 31 March 2024 \n   \n 1.            BASIS OF PREPARATION AND PRINCIPAL ACCOUNTING POLICIES \n   \n Diploma PLC (the \"Company\") is a public limited company registered and domiciled in England and Wales.  The condensed set of consolidated financial statements (the \"financial statements\") for the six months ended 31 March 2024 comprise the Company and its subsidiaries (together referred to as \"the Group\"). \n   \n The condensed information presented for the financial year ended 30 September 2023 does not constitute full statutory accounts as defined in section 434 of the Companies Act 2006. Those statutory accounts have been reported on by the Company's auditor and delivered to the Registrar of Companies. The report of the auditor was (i) unqualified, (ii) did not include a reference to any matters to which the auditors drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498 (2) or (3) of the Companies Act 2006. Except where otherwise stated, the figures for the six months ended 31 March 2023 were extracted from the 2023 Half Year Report, which was unaudited. \n   \n The Group's audited consolidated financial statements for the year ended 30 September 2023 are available on the Company's website ( www.diplomaplc.com ) or upon request from the Company's registered office at Diploma PLC, 10-11 Charterhouse Square, London, EC1M 6EE. \n   \n 1.1     Statement of compliance \n The financial statements included in this Half Year Announcement for the six months ended 31 March 2024 have been prepared on a going concern basis and in accordance with UK-adopted International Accounting Standard 34, Interim Financial Reporting and the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority. The financial statements do not include all of the information required for full annual consolidated financial statements and should be read in conjunction with the Group's audited consolidated financial statements for the year ended 30 September 2023. \n   \n The Half Year financial statements were approved by the Board of Directors on 13 May 2024; they have not been audited by the Company's auditor. \n   \n 1.2            Significant accounting policies \n The accounting policies applied by the Group in this set of financial statements are the same as those applied by the Group in its audited consolidated financial statements for the year ended 30 September 2023, except for the amount included in respect of taxation and the application of hedge accounting for foreign currency hedges and net investment hedges. The adoption of the new policies in respect of hedging did not have a material impact over the interim financial statements.   \n   \n As in previous Half Year Announcements, taxation has been calculated by applying the Directors' best estimate of the annual rates of taxation to taxable profits for the period. In the audited consolidated financial statements for the full year, the taxation balances are based on draft tax computations prepared for each business within the Group.  \n   \n 1.3     Risk management \n The Group's overall management of financial risks is carried out by a central team under policies and procedures which are reviewed by the Board. The financial risks to which the Group is exposed are those of credit, liquidity, foreign currency, interest rate and capital management. An explanation of each of these risks and how the Group manages them is included in the Annual Report & Accounts for the year ended 30 September 2023. Further explanation of the Group's principal risks and uncertainties and Going Concern are set out in the narrative of this Half Year Report. \n   \n Notes to the Condensed Consolidated Financial Statements \n For the six months ended 31 March 2024 \n   \n 1.3     Risk management (Continued) \n There is no material difference between the book value and fair value of the Group's financial assets and financial liabilities as at 31 March 2024. The basis for determining the fair value is as follows: \n   \n \n \n \n \n - \n \n \n Derivatives: Forward contracts and interest rate swaps are designated as level 2 assets (in the fair value hierarchy) and fair-valued at 31 March 2024 with the gains and losses taken to equity. The fair value of the forward contracts and interest rate swaps as at 31 March is £nil (30 September 2023: £2.4m asset). \n \n \n \n \n - \n \n \n Trade and other receivables: As the majority of the trade and other receivables have a remaining life of less than 12 months, the book value is deemed to be reflective of the fair value. \n \n \n \n \n - \n \n \n Lease and other liabilities: The carrying amount represents the discounted value of the expected liability which is deemed to reflect the fair value. \n \n \n \n \n   \n   \n 1.4       Estimates and judgements \n The preparation of these financial statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates. \n   \n The accounting estimates and judgements made by management in applying the Group's accounting policies that have the most significant effect on the amounts included within these consolidated financial statements, were the same as those that applied to the Group's audited consolidated financial statements for the year ended 30 September 2023 as set out on page 179 - 180 of the 2023 Annual Report & Accounts. \n   \n   \n 2.            ANALYSIS OF OPERATING EXPENSES / (INCOME) \n   \n \n \n \n \n \n \n \n \n \n \n Unaudited \n \n \n Unaudited \n \n \n Audited \n \n \n \n \n \n \n \n \n \n \n Six months to 31 Mar 2024 \n \n \n Six months to 31 Mar 2023 \n \n \n Year to 30 Sep 2023 \n \n \n \n \n \n \n \n \n \n \n Adjusted 1 \n \n \n Adjust-ments 1 \n \n \n Total \n \n \n Adjusted 1 \n \n \n Adjust-ments 1 \n \n \n Total \n \n \n Total \n \n \n \n \n \n \n \n \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n \n \n Cost of inventories sold \n \n \n \n \n \n 345.7 \n \n \n 5.4 \n \n \n 351.1 \n \n \n 319.4 \n \n \n - \n \n \n 319.4 \n \n \n 658.0 \n \n \n \n \n Employee costs \n \n \n \n \n \n 112.8 \n \n \n - \n \n \n 112.8 \n \n \n 102.0 \n \n \n 1.9 \n \n \n 103.9 \n \n \n 210.0 \n \n \n \n \n Depreciation of property, plant and equipment \n \n \n \n \n \n 7.4 \n \n \n   \n - \n \n \n 7.4 \n \n \n 6.3 \n \n \n   \n - \n \n \n 6.3 \n \n \n 12.8 \n \n \n \n \n Depreciation of right-of-use assets \n \n \n \n \n \n 7.7 \n \n \n   \n - \n \n \n 7.7 \n \n \n 6.7 \n \n \n   \n - \n \n \n 6.7 \n \n \n 14.8 \n \n \n \n \n Amortisation \n \n \n \n \n \n 0.5 \n \n \n 28.2 \n \n \n 28.7 \n \n \n 0.4 \n \n \n 25.3 \n \n \n 25.7 \n \n \n 53.9 \n \n \n \n \n Net impairment losses on trade receivables \n \n \n \n \n \n 0.6 \n \n \n   \n - \n \n \n 0.6 \n \n \n 1.1 \n \n \n   \n - \n \n \n 1.1 \n \n \n 2.5 \n \n \n \n \n Other operating expenses \n \n \n   \n \n \n 38.2 \n \n \n 3.8 \n \n \n 42.0 \n \n \n 37.2 \n \n \n (10.0) \n \n \n 27.2 \n \n \n 65.0 \n \n \n \n \n Operating expenses \n \n \n \n \n \n 512.9 \n \n \n 37.4 \n \n \n 550.3 \n \n \n 473.1 \n \n \n 17.2 \n \n \n 490.3 \n \n \n 1,017.0 \n \n \n \n \n   \n 1 The adjustments to operating expenses are made in relation to acquisition related and other charges, as defined in note 13.3, totalling £37.4m (2023: £17.2m) and comprise £5.4m (2023: £nil) of fair value adjustments to inventory acquired through acquisitions recognised in cost of inventories sold, £28.2m (2023: £25.3m) of amortisation of acquisition intangible assets and £3.8m (2023 £4.1m) of acquisition expenses. During the period ended 31 March 2024, the gain on disposal of businesses was £nil (2023: £12.2m). \n   \n Notes to the Condensed Consolidated Financial Statements \n For the six months ended 31 March 2024 \n   \n 3.            BUSINESS SECTOR ANALYSIS  \n   \n The Chief Operating Decision Maker (\"CODM\") for the purposes of IFRS 8 is the Chief Executive Officer. The financial performance of the Sectors is reported to the CODM monthly and this information is used to allocate resources on an appropriate basis. \n   \n Sector information is presented in this Half Year Announcement in respect of the Group's business Sectors. The business sector reporting format reflects the Group's management and internal reporting structure. The geographic sector reporting represents results by origin. The Group's financial results have not, historically, been subject to significant seasonal trends. In the year ended 30 September 2023, the Group earned 48.6% of its annual revenues and 46.3% of its annual adjusted operating profits in the first six months of the year. This phasing between the first and second half was partly impacted by the timing of acquisitions which favoured the second half of the year. \n   \n Sector revenue represents revenue from external customers; there is no inter-sector revenue. Sector results, assets and liabilities include items directly attributable to a Sector. \n   \n \n \n \n \n \n \n \n Revenue \n \n \n Adjusted operating profit \n \n \n Operating profit \n \n \n \n \n \n \n \n 6 mths 31 Mar \n \n \n 6 mths 31 Mar \n \n \n 12 mths 30 Sep \n \n \n 6 mths 31 Mar \n \n \n 6 mths 31 Mar \n \n \n 12 mths 30 Sep \n \n \n 6mths 31 Mar \n \n \n 6 mths 31 Mar \n \n \n 12 mths 30 Sep \n \n \n \n \n £m \n \n \n 2024 \n \n \n 2023 \n \n \n 2023 \n \n \n 2024 \n \n \n 2023 \n \n \n 2023 \n \n \n 2024 \n \n \n 2023 \n \n \n 2023 \n \n \n \n \n   \n \n \n   \n \n \n \n \n \n   \n \n \n   \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n \n \n By Sector \n \n \n   \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Controls \n \n \n   288.1 \n \n \n   278.8 \n \n \n 568.4 \n \n \n 69.9 \n \n \n 64.3 \n \n \n 136.6 \n \n \n 53.7 \n \n \n 57.7 \n \n \n 112.9 \n \n \n \n \n Seals \n \n \n 241.2 \n \n \n 198.4 \n \n \n 419.0 \n \n \n 44.3 \n \n \n 35.7 \n \n \n 79.0 \n \n \n 27.8 \n \n \n 29.3 \n \n \n 55.8 \n \n \n \n \n Life Sciences \n \n \n 109.0 \n \n \n 105.6 \n \n \n 212.9 \n \n \n 21.6 \n \n \n 20.9 \n \n \n 43.2 \n \n \n 16.9 \n \n \n 16.7 \n \n \n 36.4 \n \n \n \n \n Corporate \n \n \n - \n \n \n - \n \n \n - \n \n \n (10.4) \n \n \n (11.2) \n \n \n (21.8) \n \n \n (10.4) \n \n \n (11.2) \n \n \n (21.8) \n \n \n \n \n \n \n \n 638.3 \n \n \n 582.8 \n \n \n 1,200.3 \n \n \n 125.4 \n \n \n 109.7 \n \n \n 237.0 \n \n \n 88.0 \n \n \n 92.5 \n \n \n 183.3 \n \n \n \n \n   \n \n \n   \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n \n \n By Geographic Area \n \n \n   \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n \n \n United Kingdom \n \n \n 130.8 \n \n \n 137.2 \n \n \n 267.1 \n \n \n 13.9 \n \n \n 14.4 \n \n \n 28.8 \n \n \n   \n \n \n \n \n \n \n \n \n \n \n Rest of Europe \n \n \n 134.6 \n \n \n 97.7 \n \n \n 210.3 \n \n \n 24.6 \n \n \n 15.3 \n \n \n 34.5 \n \n \n   \n \n \n \n \n \n \n \n \n \n \n USA \n \n \n 278.3 \n \n \n 256.5 \n \n \n 537.6 \n \n \n 67.7 \n \n \n 60.3 \n \n \n 132.2 \n \n \n   \n \n \n \n \n \n \n \n \n \n \n Rest of World \n \n \n 94.6 \n \n \n 91.4 \n \n \n 185.3 \n \n \n 19.2 \n \n \n 19.7 \n \n \n 41.5 \n \n \n   \n \n \n \n \n \n \n \n \n \n \n \n \n \n 638.3 \n \n \n 582.8 \n \n \n 1,200.3 \n \n \n 125.4 \n \n \n 109.7 \n \n \n 237.0 \n \n \n   \n \n \n \n \n \n \n \n \n \n \n   \n The Group has re-presented the comparative for the period ended 31 March 2023 in relation to the geographic segment analysis to reflect USA separately. This is due to the increasing operations in that territory and provides more information that is relevant to the users of the financial statements. \n   \n Notes to the Condensed Consolidated Financial Statements \n For the six months ended 31 March 2024 \n   \n 3.            BUSINESS SECTOR ANALYSIS (Continued) \n   \n   \n \n \n \n \n \n \n \n Total assets \n \n \n Total liabilities \n \n \n Net assets \n \n \n \n \n \n \n \n 31 Mar \n \n \n 31 Mar \n \n \n 30 Sep \n \n \n 31 Mar \n \n \n 31 Mar \n \n \n 30 Sep \n \n \n 31 Mar \n \n \n 31 Mar \n \n \n 30 Sep \n \n \n \n \n £m \n \n \n 2024 \n \n \n 2023 \n \n \n 2023 \n \n \n 2024 \n \n \n 2023 \n \n \n 2023 \n \n \n 2024 \n \n \n 2023 \n \n \n 2023 \n \n \n \n \n   \n \n \n   \n \n \n \n \n \n   \n \n \n   \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n \n \n By Sector \n \n \n   \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Controls \n \n \n 622.2 \n \n \n 643.1 \n \n \n 640.4 \n \n \n (93.5) \n \n \n (79.7) \n \n \n (96.1) \n \n \n  528.7 \n \n \n  563.4  \n \n \n 544.3 \n \n \n \n \n Seals \n \n \n 608.1 \n \n \n 423.3 \n \n \n 628.9 \n \n \n (112.1) \n \n \n (96.5) \n \n \n (119.6) \n \n \n 496.0 \n \n \n  326.8  \n \n \n 509.3 \n \n \n \n \n Life Sciences \n \n \n 250.7 \n \n \n 245.9 \n \n \n 244.1 \n \n \n (52.7) \n \n \n (45.9) \n \n \n (43.3) \n \n \n  198.0 \n \n \n  200.0  \n \n \n 200.8 \n \n \n \n \n Corporate assets/(liabilities) \n \n \n 65.1 \n \n \n 93.1 \n \n \n 75.9 \n \n \n (407.2) \n \n \n (320.3) \n \n \n (428.3) \n \n \n (342.1) \n \n \n (227.2) \n \n \n (352.4) \n \n \n \n \n \n \n \n 1,546.1 \n \n \n 1,405.4 \n \n \n 1,589.3 \n \n \n (665.5) \n \n \n (542.4) \n \n \n (687.3) \n \n \n  880.6  \n \n \n  863.0  \n \n \n  902.0 \n \n \n \n \n   \n Sector assets exclude cash and cash equivalents, deferred tax assets and corporate assets that cannot be allocated on a reasonable basis to a business Sector. Sector liabilities exclude bank borrowings, retirement benefit obligations, deferred tax liabilities, acquisition liabilities and corporate liabilities that cannot be allocated on a reasonable basis to a business Sector. These items that cannot be allocated on a reasonable basis to a business Sector are shown collectively as \"corporate assets/(liabilities)\". \n   \n \n \n \n \n \n \n \n Capital expenditure \n \n \n Depreciation \n \n \n \n \n \n \n \n 31 Mar \n \n \n 31 Mar \n \n \n 30 Sep \n \n \n 31 Mar \n \n \n 31 Mar \n \n \n 30 Sep \n \n \n \n \n £m \n \n \n 2024 \n \n \n 2023 \n \n \n 2023 \n \n \n 2024 \n \n \n 2023 \n \n \n 2023 \n \n \n \n \n   \n \n \n   \n \n \n \n \n \n   \n \n \n   \n \n \n \n \n \n \n \n \n \n \n By Sector \n \n \n   \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n \n \n Controls \n \n \n 3.3 \n \n \n 2.7 \n \n \n 5.9 \n \n \n 2.4 \n \n \n 2.4 \n \n \n 4.6 \n \n \n \n \n Seals \n \n \n 3.2 \n \n \n 3.8 \n \n \n 9.0 \n \n \n 3.2 \n \n \n 2.3 \n \n \n 5.0 \n \n \n \n \n Life Sciences \n \n \n 3.1 \n \n \n 3.5 \n \n \n 7.9 \n \n \n 2.2 \n \n \n 1.9 \n \n \n 4.0 \n \n \n \n \n Corporate \n \n \n 0.1 \n \n \n  0.2 \n \n \n 0.3 \n \n \n 0.1 \n \n \n 0.1 \n \n \n 0.2 \n \n \n \n \n \n \n \n 9.7 \n \n \n 10.2 \n \n \n 23.1 \n \n \n 7.9 \n \n \n 6.7 \n \n \n 13.8 \n \n \n \n \n   \n A further £7.7m (2023: £6.7m) of depreciation was incurred on right-of-use assets (note 2). Depreciation also includes amortisation of other intangible assets, largely software. \n   \n Notes to the Condensed Consolidated Financial Statements \n For the six months ended 31 March 2024 \n   \n 4.            FINANCIAL EXPENSE, NET \n \n \n \n \n \n \n \n 31 Mar \n 2024 \n \n \n 31 Mar \n 2023 \n \n \n 30 Sep \n 2023 \n \n \n \n \n \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n \n \n Interest (income)/ expense and similar charges \n \n \n   \n \n \n \n \n \n \n \n \n \n \n -  bank facility and commitment fees \n \n \n 0.7 \n \n \n 0.7 \n \n \n 1.6 \n \n \n \n \n -  interest income on short term deposits \n \n \n (0.1) \n \n \n (0.2) \n \n \n (0.4) \n \n \n \n \n -  interest expense on bank borrowings \n \n \n 7.8 \n \n \n 9.2 \n \n \n 16.6 \n \n \n \n \n -  notional interest income on the defined benefit pension schemes \n \n \n (0.2) \n \n \n (0.2) \n \n \n (0.4) \n \n \n \n \n -  amortisation of capitalised borrowing fees \n \n \n - \n \n \n 0.1 \n \n \n 0.2 \n \n \n \n \n -  interest on lease liabilities \n \n \n 2.0 \n \n \n 1.4 \n \n \n  2.8 \n \n \n \n \n Net interest expense and similar charges \n \n \n 10.2 \n \n \n 11.0 \n \n \n 20.4 \n \n \n \n \n - acquisition related finance charges, net \n \n \n - \n \n \n 2.8 \n \n \n 7.3 \n \n \n \n \n Financial expense, net \n \n \n 10.2 \n \n \n 13.8 \n \n \n 27.7 \n \n \n \n \n   \n Acquisition related finance charges includes unwind of discount on and remeasurement of acquisition liabilities of £0.4m expense (2023: £0.9m expense) and the amortisation of capitalised borrowing fees on acquisition related borrowings of £0.4m expense (2023: £0.9m expense), net of interest income on deferred receivables from disposals of £0.2m income (2023: £0.4m income) and fair value remeasurements of put options for future minority purchases of £0.6m income (2023: £1.4m expense). \n   \n 5.            TAXATION \n \n \n \n \n \n \n \n 31 Mar \n 2024 \n \n \n 31 Mar \n 2023 \n \n \n 30 Sep \n 2023 \n \n \n \n \n \n \n \n £m \n \n \n £m \n \n \n £m \n \n \n \n \n UK tax \n \n \n 7.7 \n \n \n 7.2 \n \n \n 8.9 \n \n \n \n \n Overseas tax \n \n \n 12.0 \n \n \n 11.8 \n \n \n 28.4 \n \n \n \n \n Total tax on profit for the period \n \n \n 19.7 \n \n \n 19.0 \n \n \n 37.3 \n \n \n \n \n   \n Taxation on profits before tax has been calculated by applying the Directors' best estimate of the annual rates of taxation to taxable profits for the period. The Group's adjusted effective rate of tax on adjusted profit before tax is 24.0% (September 2023: 24.0%). \n   \n Notes to the Condensed Consolidated Financial Statements \n For the six months ended 31 March 2024 \n   \n 6.            EARNINGS PER SHARE \n   \n Basic earnings per share \n Basic earnings per ordinary 5p share are calculated on the basis of the weighted average number of ordinary shares in issue during the period of 134,009,865 (2023: 125,360,523) and the profit for the period attributable to shareholders of £57.7m (2023: £59.3m). Basic earnings per share is 43.1p (2023: 47.3p). Diluted earnings per share is 43.0p (2023: 47.1p) and is based on the average number of ordinary shares (which includes any potentially dilutive shares) of 134,328,842 (2023: 125,927,286). \n   \n Adjusted earnings per share \n Adjusted earnings per share, defined in note 13, is calculated as follows: \n \n \n \n \n \n \n \n 31 Mar 2024 \n \n \n 31 Mar 2023 \n \n \n 30 Sep \n 2023 \n \n \n   \n \n \n \n \n \n \n \n \n \n \n \n \n \n pence \n per share \n \n \n pence \n per share \n \n \n pence \n per share \n \n \n 31 Mar \n 2024 £m \n \n \n 31 Mar \n 2023 £m \n \n \n 30 Sep \n 2023 £m \n \n \n \n \n Profit before tax \n \n \n   \n \n \n \n \n \n \n \n \n 77.8 \n \n \n 78.7  \n \n \n 155.6  \n \n \n \n \n Tax expense \n \n \n   \n \n \n \n \n \n \n \n \n (19.7) \n \n \n (19.0) \n \n \n (37.3) \n \n \n \n \n Minority interests \n \n \n   \n \n \n \n \n \n \n \n \n (0.4) \n \n \n (0.4) \n \n \n (0.6)  \n \n \n \n \n Earnings for the period attributable to \n shareholders of the Company \n \n \n   \n     43.1 \n \n \n   \n      47.3 \n \n \n   \n 90.8 \n \n \n   \n 57.7  \n \n \n   \n 59.3  \n \n \n   \n 117.7  \n \n \n \n \n Acquisition related and other charges and acquisition related finance char...

View stock analysis, news, and events for Diploma Plc